Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
- Immunocytochemistry [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-55533 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CDCA7L Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- Immunogen sequence: VRFHSKYFTE ELRRIFIEDT DSETEDFAGF TQSDLNGKTN PEVMVVESDL SDDGKASLVS EEEEDEEEDK ATPRRSRSRR SSIGLRVAFQ FPTKKLANKP DKNSSSEQLF SSARLQNEKK TILERKKDCR QVIQREDSTS ESE
- Concentration
- 0.2 mg/mL
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of CDCA7L in Lane 1: Marker (kDa) 230, 130, 95, 72, 56, 36, 28, 17, 11; Lane 2: Human cell line RT-4. Samples were probed using a CDCA7L Polyclonal Antibody (Product # PA5-55533).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of CDCA7L in human cell line NTERA-2 using a CDCA7L Polyclonal Antibody (Product # PA5-55533).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of CDCA7L in human cell line A-431 shows positivity in nucleus & nucleoli. Samples were probed using a CDCA7L Polyclonal Antibody (Product # PA5-55533).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of CDCA7L in human cell line A-431 using a CDCA7L Polyclonal Antibody (Product # PA5-55533) shows localization to nucleus and nucleoli.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of CDCA7L in human appendix tissue shows strong nuclear positivity in lymphoid reaction center cells. Samples were probed using a CDCA7L Polyclonal Antibody (Product # PA5-55533).